FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891366322> ?p ?o ?g. }

• W2891366322 endingPage "270" @default.
• W2891366322 startingPage "258" @default.
• W2891366322 abstract "To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo-controlled studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients with radiographic axial SpA (anti-tumor necrosis factor [anti-TNF]-naive patients and patients with inadequate response or intolerance to anti-TNF, respectively); study 3 patients had nonradiographic axial SpA.In all 3 studies, patients were randomly assigned (1:1:1) to receive subcutaneous ustekinumab at 45 mg or 90 mg or placebo up to 24 weeks, after which placebo-treated patients were rerandomized to receive ustekinumab at 45 mg or 90 mg. The primary end point in studies 1 and 2 was the proportion of patients who met the Assessment of SpondyloArthritis international Society criteria for 40% improvement in disease activity (achieved an ASAS40 response). The primary end point in study 3 was the proportion of patients who achieved an ASAS20 response. Other disease activity and safety measures were also evaluated. A week 24 analysis of study 1 was preplanned to determine continuation of studies 2 and 3.For study 1, the primary and major secondary end points were not met, and the study was discontinued. As a result, studies 2 and 3 were prematurely discontinued before they were fully enrolled. For all 3 studies, neither ustekinumab dose group demonstrated clinically meaningful improvement over placebo on key efficacy end points. The proportion of patients experiencing adverse events in the ustekinumab groups was consistent with that in previous studies.In these 3 placebo-controlled trials, efficacy of ustekinumab in the treatment of axial SpA was not demonstrated. The safety profile was consistent with that of studies in other indications." @default.
• W2891366322 created "2018-09-27" @default.
• W2891366322 creator A5004716253 @default.
• W2891366322 creator A5015084747 @default.
• W2891366322 creator A5018452137 @default.
• W2891366322 creator A5025049914 @default.
• W2891366322 creator A5030325032 @default.
• W2891366322 creator A5030899986 @default.
• W2891366322 creator A5033958031 @default.
• W2891366322 creator A5034952463 @default.
• W2891366322 creator A5052613606 @default.
• W2891366322 creator A5061216714 @default.
• W2891366322 creator A5085469512 @default.
• W2891366322 creator A5085745432 @default.
• W2891366322 creator A5089158758 @default.
• W2891366322 date "2018-12-29" @default.
• W2891366322 modified "2023-10-17" @default.
• W2891366322 title "Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis" @default.
• W2891366322 cites W1496723053 @default.
• W2891366322 cites W1806191714 @default.
• W2891366322 cites W1828609470 @default.
• W2891366322 cites W1835490086 @default.
• W2891366322 cites W1836263069 @default.
• W2891366322 cites W1966756689 @default.
• W2891366322 cites W1967744663 @default.
• W2891366322 cites W1976173775 @default.
• W2891366322 cites W2012118725 @default.
• W2891366322 cites W2030187620 @default.
• W2891366322 cites W2046579578 @default.
• W2891366322 cites W2048020246 @default.
• W2891366322 cites W2094084679 @default.
• W2891366322 cites W2097896494 @default.
• W2891366322 cites W2107909189 @default.
• W2891366322 cites W2108984264 @default.
• W2891366322 cites W2116618422 @default.
• W2891366322 cites W2116956799 @default.
• W2891366322 cites W2118596556 @default.
• W2891366322 cites W2118706017 @default.
• W2891366322 cites W2122470737 @default.
• W2891366322 cites W2129257749 @default.
• W2891366322 cites W2134009713 @default.
• W2891366322 cites W2135067598 @default.
• W2891366322 cites W2135336890 @default.
• W2891366322 cites W2137101132 @default.
• W2891366322 cites W2139525798 @default.
• W2891366322 cites W2149555923 @default.
• W2891366322 cites W2156605473 @default.
• W2891366322 cites W2162319272 @default.
• W2891366322 cites W2212226399 @default.
• W2891366322 cites W2336136362 @default.
• W2891366322 cites W2588853206 @default.
• W2891366322 cites W2608831233 @default.
• W2891366322 cites W2752721387 @default.
• W2891366322 cites W2802706970 @default.
• W2891366322 cites W4211203343 @default.
• W2891366322 cites W4233817719 @default.
• W2891366322 cites W4248269869 @default.
• W2891366322 doi "https://doi.org/10.1002/art.40728" @default.
• W2891366322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30225992" @default.
• W2891366322 hasPublicationYear "2018" @default.
• W2891366322 type Work @default.
• W2891366322 sameAs 2891366322 @default.
• W2891366322 citedByCount "221" @default.
• W2891366322 countsByYear W28913663222018 @default.
• W2891366322 countsByYear W28913663222019 @default.
• W2891366322 countsByYear W28913663222020 @default.
• W2891366322 countsByYear W28913663222021 @default.
• W2891366322 countsByYear W28913663222022 @default.
• W2891366322 countsByYear W28913663222023 @default.
• W2891366322 crossrefType "journal-article" @default.
• W2891366322 hasAuthorship W2891366322A5004716253 @default.
• W2891366322 hasAuthorship W2891366322A5015084747 @default.
• W2891366322 hasAuthorship W2891366322A5018452137 @default.
• W2891366322 hasAuthorship W2891366322A5025049914 @default.
• W2891366322 hasAuthorship W2891366322A5030325032 @default.
• W2891366322 hasAuthorship W2891366322A5030899986 @default.
• W2891366322 hasAuthorship W2891366322A5033958031 @default.
• W2891366322 hasAuthorship W2891366322A5034952463 @default.
• W2891366322 hasAuthorship W2891366322A5052613606 @default.
• W2891366322 hasAuthorship W2891366322A5061216714 @default.
• W2891366322 hasAuthorship W2891366322A5085469512 @default.
• W2891366322 hasAuthorship W2891366322A5085745432 @default.
• W2891366322 hasAuthorship W2891366322A5089158758 @default.
• W2891366322 hasBestOaLocation W28913663222 @default.
• W2891366322 hasConcept C126322002 @default.
• W2891366322 hasConcept C141071460 @default.
• W2891366322 hasConcept C142724271 @default.
• W2891366322 hasConcept C168563851 @default.
• W2891366322 hasConcept C197934379 @default.
• W2891366322 hasConcept C203092338 @default.
• W2891366322 hasConcept C204243189 @default.
• W2891366322 hasConcept C204787440 @default.
• W2891366322 hasConcept C27081682 @default.
• W2891366322 hasConcept C2778975655 @default.
• W2891366322 hasConcept C2779134260 @default.
• W2891366322 hasConcept C2780132546 @default.
• W2891366322 hasConcept C71924100 @default.
• W2891366322 hasConceptScore W2891366322C126322002 @default.

• next